Literature DB >> 8921479

An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project.

M Pladevall1, D C Goff, M Z Nichaman, F Chan, D Ramsey, C Ortíz, D R Labarthe.   

Abstract

BACKGROUND: The identification of myocardial infarction (MI) is typically based on finding events designated by a nosologist with the appropriate International Classification of Diseases (ICD) code, currently code 410. These codes are applied based on review of medical records or death certificates. However, other factors, including reimbursement considerations, may influence the coding process, especially for hospitalizations. Thus, the validity of using ICD code 410 to identify MI must be assessed.
METHODS: The Corpus Christi Heart Project (CCHP) is a population-based surveillance programme for hospitalized MI. Patients were identified using concurrent ascertainment in coronary care units and retrospective review of medical records. Events were validated as definite or possible MI using data regarding chest pain, electrocardiographic changes and cardiac enzymes. The validity of using ICD code 410 to identify cases of MI was assessed by calculating the sensitivity, specificity, predictive values and efficiency of ICD code 410 versus the CCHP 'gold standard'.
RESULTS: Use of ICD code 410 identified 80.9% (401/496) of definite MI, but only 19.0% (243/1280) of possible MI. Only 12.3% (90/734) of discharges with an ICD 410 code received a 'no MI' designation based on the 'gold standard'. The efficiency of ICD code 410 for identifying MI was 92.0% for definite MI and 77.1% for definite and possible MI.
CONCLUSIONS: The use of ICD code 410 to identify hospitalized cases of MI results in a modestly biased overestimate of the number of definite MI hospitalizations; however, this approach warrants consideration due to the expense of validation procedures.

Entities:  

Mesh:

Year:  1996        PMID: 8921479     DOI: 10.1093/ije/25.5.948

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  25 in total

1.  Pursuing integration of performance measures into electronic medical records: beta-adrenergic receptor antagonist medications.

Authors:  M Weiner; T E Stump; C M Callahan; J N Lewis; C J McDonald
Journal:  Qual Saf Health Care       Date:  2005-04

2.  Myocardial infarction risk among patients with fractures receiving bisphosphonates.

Authors:  Cory B Pittman; Lisa A Davis; Angelique L Zeringue; Liron Caplan; Kent R Wehmeier; Jeffrey F Scherrer; Hong Xian; Francesca E Cunningham; Jay R McDonald; Alexis Arnold; Seth A Eisen
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

3.  Managing data quality for a drug safety surveillance system.

Authors:  Abraham G Hartzema; Christian G Reich; Patrick B Ryan; Paul E Stang; David Madigan; Emily Welebob; J Marc Overhage
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

4.  Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study.

Authors:  Montika Bush; Til Stürmer; Sally C Stearns; Ross J Simpson; M Alan Brookhart; Wayne Rosamond; Anna M Kucharska-Newton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-06       Impact factor: 2.890

5.  The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012.

Authors:  Yariv Gerber; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Am J Med       Date:  2014-09-28       Impact factor: 4.965

6.  Cardiovascular events and death in children exposed and unexposed to ADHD agents.

Authors:  Hedi Schelleman; Warren B Bilker; Brian L Strom; Stephen E Kimmel; Craig Newcomb; James P Guevara; Gregory W Daniel; Mark J Cziraky; Sean Hennessy
Journal:  Pediatrics       Date:  2011-05-16       Impact factor: 7.124

7.  Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

Authors:  H M Crane; S R Heckbert; D R Drozd; M J Budoff; J A C Delaney; C Rodriguez; P Paramsothy; W B Lober; G Burkholder; J H Willig; M J Mugavero; W C Mathews; P K Crane; R D Moore; S Napravnik; J J Eron; P Hunt; E Geng; P Hsue; G S Barnes; J McReynolds; I Peter; C Grunfeld; M S Saag; M M Kitahata
Journal:  Am J Epidemiol       Date:  2014-03-11       Impact factor: 4.897

8.  Racial and ethnic disparities in cardiac catheterization for acute myocardial infarction in the United States, 1995--2001.

Authors:  Alain G Bertoni; Kelly L Goonan; Denise E Bonds; Melicia C Whitt; David C Goff; Frederick L Brancati
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

9.  Paradoxical lower postmyocardial infarction mortality among veteran women--does a sex bias exist in the Veterans Affairs medical system?

Authors:  Masoor Kamalesh; Usha Subramanian; Anahita Ariana; George J Eckert; Stephen Sawada
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

10.  Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.

Authors:  Amy Metcalfe; Annabelle Neudam; Samantha Forde; Mingfu Liu; Saskia Drosler; Hude Quan; Nathalie Jetté
Journal:  Health Serv Res       Date:  2012-06-28       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.